Evaluation of Bevacizumab effect on diabetic macular edema in diabetic patients .

Phase 2

Recruiting

• Conditions: Diabetic macular edema.; Diabetic retinopathy; H36.0

• Registration Number: IRCT20190518043622N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 November 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 35

Inclusion Criteria

Patients with diabetic macular edema
age between 30-75 years old
Central macular thickness more than 300 microne based on OCT measurement

Exclusion Criteria

Myopia more than 6 diopters
other macular diseases like macular hole and CNV
Some drugs :Hydroxycloroquine consumption
Previous history of chemotherapy and radiotherapy
History of vitrectomy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in macular thickness. Timepoint: Before intervention and 1 month after intervention. Method of measurement: Evaluation of macular thickness with OCT angiography.;Change in geometrical feature of FAZ area. Timepoint: Before intervention and 1 month after intervention. Method of measurement: Evaluation of geometrical features of macula with OCT angiography and analyzing it with MATLAB.